Pfizer Loses Legal Bid to Block Novo Nordisk’s Metsera Offer (3)

A judge denied Pfizer Inc.’s request to temporarily block Novo Nordisk A/S’ $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s objections to the deal don’t warrant a delay.

Delaware Chancery Judge Morgan Zurn concluded Wednesday that Pfizer didn’t level legitimate complaints about Novo’s effort to supplant it as New York-based Metsera’s buyer and refused to bar the Danish company from proceeding with the transaction.

Pfizer has matched Novo’s offer for Metsera, the Financial Times reported late Wednesday, citing unidentified people familiar with the matter. The company had already raised its ...